← All companies
BKYI
BIO-key International, Inc.
$3.76
-0.57 -13.16%
Key statistics
from XBRL data in SEC filingsMarket cap
$4.08M
Revenue (TTM)
$6.48M
Net income (TTM)
$7.69M
EPS (TTM)
$-9.40
P/E ratio
—
Dividend yield
—
Free cash flow
-$4.68M
Cash
$2.25M
Total assets
$8.16M
Gross margin
77.3%
52-week range
$3.10 – $19.70
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Changed accountants
Jul 9, 2026
8-K
Regulation FD disclosure
Jul 7, 2026
10-Q
Quarter ended 2026-03-31
Jun 22, 2026
10-K/A
Fiscal year ended 2025-12-31
Jun 15, 2026
10-K
Fiscal year ended 2025-12-31
Jun 12, 2026
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
Jun 10, 2026
8-K
Results of operations (earnings release)
May 18, 2026
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
May 12, 2026
8-K
Modified rights of security holders; Amended charter or bylaws; Other events
Apr 29, 2026
8-K
Shareholder vote results
Apr 24, 2026
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
Apr 22, 2026
8-K
Results of operations (earnings release)
Apr 20, 2026
8-K
Results of operations (earnings release)
Mar 31, 2026
8-K
Results of operations (earnings release)
Mar 4, 2026
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K
Results of operations (earnings release)
Nov 14, 2025
8-K
Delisting notice or listing-rule failure
Nov 7, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Oct 30, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Oct 3, 2025
8-K
Director or officer change
Aug 20, 2025
10-Q
Quarter ended 2025-06-30
Aug 13, 2025
8-K
Shareholder vote results
Aug 13, 2025
8-K
Results of operations (earnings release)
Aug 13, 2025
8-K
Results of operations (earnings release); Delisting notice or listing-rule failure
May 15, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Delisting notice or listing-rule failure; Regulation FD disclosure
Apr 24, 2025
10-K
Fiscal year ended 2024-12-31
Apr 23, 2025
8-K
Results of operations (earnings release)
Mar 27, 2025
8-K
Entered a material agreement; Unregistered sale of equity
Jan 16, 2025
8-K
Other events
Dec 3, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Dec 3, 2024
8-K
Results of operations (earnings release)
Nov 15, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Sep 16, 2024
8-K
Shareholder vote results
Aug 28, 2024
8-K
Results of operations (earnings release)
Aug 15, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Jun 28, 2024
10-K/A
Fiscal year ended 2023-12-31
Jun 20, 2024
8-K
Results of operations (earnings release)
Jun 17, 2024